Giglio, Rosaria Vincenza
 Distribuzione geografica
Continente #
NA - Nord America 4.917
EU - Europa 3.100
AS - Asia 2.306
SA - Sud America 534
AF - Africa 79
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.964
Nazione #
US - Stati Uniti d'America 4.832
IT - Italia 1.715
SG - Singapore 882
CN - Cina 628
BR - Brasile 428
HK - Hong Kong 281
RU - Federazione Russa 253
DE - Germania 233
VN - Vietnam 193
GB - Regno Unito 164
PL - Polonia 145
FI - Finlandia 111
IE - Irlanda 80
FR - Francia 75
IN - India 63
SE - Svezia 58
CA - Canada 42
AR - Argentina 36
AT - Austria 36
RO - Romania 35
ES - Italia 34
TR - Turchia 34
UA - Ucraina 34
NL - Olanda 33
BD - Bangladesh 29
IQ - Iraq 28
MX - Messico 28
JP - Giappone 26
KR - Corea 22
EG - Egitto 18
UZ - Uzbekistan 18
AU - Australia 17
BE - Belgio 17
ID - Indonesia 16
IR - Iran 16
ZA - Sudafrica 15
MA - Marocco 14
EC - Ecuador 13
BG - Bulgaria 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
CO - Colombia 11
PK - Pakistan 11
CH - Svizzera 10
IL - Israele 10
PY - Paraguay 10
LT - Lituania 9
SA - Arabia Saudita 9
BO - Bolivia 8
CZ - Repubblica Ceca 8
NZ - Nuova Zelanda 8
KE - Kenya 7
CI - Costa d'Avorio 6
DK - Danimarca 6
VE - Venezuela 6
AL - Albania 5
GR - Grecia 5
MY - Malesia 5
NP - Nepal 5
PH - Filippine 5
UY - Uruguay 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
PE - Perù 4
PT - Portogallo 4
TN - Tunisia 4
DZ - Algeria 3
ET - Etiopia 3
NG - Nigeria 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EE - Estonia 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
JO - Giordania 2
LU - Lussemburgo 2
ME - Montenegro 2
NI - Nicaragua 2
SD - Sudan 2
SY - Repubblica araba siriana 2
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
EU - Europa 1
GH - Ghana 1
GN - Guinea 1
IM - Isola di Man 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
MC - Monaco 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
Totale 10.959
Città #
Ashburn 681
Singapore 545
Fairfield 493
Chandler 477
Hong Kong 271
Palermo 263
Wilmington 224
Seattle 195
Houston 194
Woodbridge 177
Cambridge 176
Beijing 146
Ann Arbor 120
Los Angeles 108
Zgierz 105
Medford 101
Moscow 100
Rome 100
Des Moines 97
New York 97
Dallas 90
Milan 79
Hefei 77
Altamura 76
Dublin 74
Princeton 66
San Diego 63
Lawrence 62
Ho Chi Minh City 59
Chicago 55
The Dalles 55
Santa Clara 52
London 44
São Paulo 43
Buffalo 40
Hanoi 39
Nuremberg 38
Boardman 32
Ludwigshafen am Rhein 30
Venice 30
Helsinki 27
Nanjing 27
Frankfurt am Main 24
Lappeenranta 22
Munich 21
Naples 21
Redwood City 21
Warsaw 21
Falls Church 20
Florence 20
Pune 20
San Paolo di Civitate 20
Montreal 19
Tokyo 18
Atlanta 17
Bari 17
Bremen 16
Brooklyn 16
Changsha 16
Jinan 16
Napoli 16
Rio de Janeiro 16
Vienna 16
Boston 15
Cagliari 15
Alcamo 14
Brussels 14
Da Nang 14
Dearborn 14
Hebei 14
Nanchang 14
Shenyang 14
Tashkent 14
Turin 14
Amsterdam 13
Denver 13
Orem 13
Catania 12
Falkenstein 12
Padova 12
Phoenix 12
Poplar 12
Tianjin 12
Wroclaw 12
Al Mansurah 11
Ankara 11
Baghdad 11
Genoa 11
Guangzhou 11
Johannesburg 11
Kilburn 11
Pisa 11
Salt Lake City 11
Columbus 10
Edinburgh 10
Melbourne 10
Miami 10
Seoul 10
Tulsa 10
Biên Hòa 9
Totale 6.668
Nome #
PROBIOTICI E TERAPIA CONVENZIONALE: NUOVE FRONTIERE NELLA GESTIONE DELLE MANIFESTAZIONI ARTICOLARI DELLE MALATTIE INFIAMMATORIE INTESTINALI (IBD) 785
Bergamot reduces plasma lipids, atherogenic small dense LDL, and subclinical atherosclerosis in subjects with moderate hypercholesterolemia: A 6 months prospective study 250
Monocyte distribution width (MDW) as a screening tool for sepsis in the Emergency Department 233
Effects of Chitosan on Plasma Lipids and Lipoproteins: A 4-Month Prospective Pilot Study 215
Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 And Ghrelin Levels In Patients With Type 2 Diabetes: a prospective pilot study. 195
The Role of Nutraceuticals in Statin Intolerant Patients 192
Management of Statin Intolerance in 2018: Still More Questions Than Answers 189
Liraglutide increases serum levels of microRNA27b,-130a and-210 in patients with type 2 diabetes mellitus: A novel epigenetic effect 183
Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study 178
Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome 177
Serum low density lipoprotein subclasses in asthma 174
The effect of bergamot on dyslipidemia 173
The Prevalence of NAFLD and Fibrosis in Bariatric Surgery Patients and the Reliability of Noninvasive Diagnostic Methods 165
A new tool for sepsis screening in the Emergency Department 163
Daily use of extra virgin olive oil with high oleocanthal concentration reduced body weight, waist circumference, alanine transaminase, inflammatory cytokines and hepatic steatosis in subjects with the metabolic syndrome: A 2-month intervention study 160
Liraglutide improves carotid intima-media thickness in patients with type-2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study 155
Gli effetti extraglicemici di liraglutide: Focus sui marker cardiometabolici 155
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: An 18-month prospective study 153
Reference interval of monocyte distribution width (MDW) in healthy blood donors 148
Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis 143
Impact of Mycobacterium tuberculosis Infection on Human B Cell Compartment and Antibody Responses 139
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study 137
Comparison of a rapid immunochromatographic test with a chemiluminescence immunoassay for detection of anti-SARS-CoV-2 IgM and IgG 135
Hepatic and circulating levels of PCSK9 in morbidly obese patients: Relation with severity of liver steatosis 131
The effects of liraglutide on glucose, inflammatory markers and lipoprotein metabolism: current knowledge and future perspectives. 129
A Nutraceutical Containing Chlorogenic Acid and Luteolin Improves Cardiometabolic Parameters in Subjects with Pre-Obesity: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study 126
Comparative analysis of biochip mosaic-based indirect immunofluorescence with enzyme-linked immunosorbent assay for diagnosing myasthenia gravis 126
Preliminary results of citraves™ effects on low density lipoprotein cholesterol and waist circumference in healthy subjects after 12 weeks: A pilot open-label study 125
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders 123
Nutraceuticals as an important part of combination therapy in dyslipidaemia 123
Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia 123
Prognostic Role of CSF β-amyloid 1-42/1-40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis 122
Advances in pharmacological treatment of type 1 diabetes during pregnancy 121
Time-dependent stability of monocyte distribution width (MDW) 120
Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders 119
Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19 118
Gestational Diabetes and the Metabolic Syndrome: Can Obesity and Small, Dense Low Density Lipoproteins Be Key Mediators Of This Association? 117
Serum lipoproteins are not associated with the severity of asthma 117
Lipid subclasses profiles and oxidative stress in aggressive periodontitis before and after treatment 117
Effects of Liraglutide on Carotid Intima-Media Thickness in Patients with Type-2 Diabetes and Non-Alcoholic Fatty Liver Disease: An 8-Month Prospective Pilot Study 115
Evaluation of anti-sars-cov-2 s-rbd igg antibodies after covid-19 mrna bnt162b2 vaccine 115
Effect of liraglutide on carotid intima-media thickness in patients with type-2 diabetes: a 4-month prospective study 114
Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: An 8-month prospective pilot study 113
A novel beneficial effect of liraglutide: the reduction in subclinical atherosclerosis in patients with type-2 diabetes. 107
COVID-19 and Alzheimer's Disease 107
Vitamin D and Multiple Sclerosis: An Open-Ended Story 106
Monocyte distribution width (MDW) as a reliable biomarker for urosepsis 105
Foxp3 and gata3 polymorphisms, vitamin d3 and multiple sclerosis 104
Monocyte distribution width as a biomarker of sepsis in the intensive care unit: A pilot study 103
The role of serum free light chain as biomarker of Myasthenia Gravis 98
The role of vitamin d as a biomarker in alzheimer’s disease 97
The Value of a Complete Blood Count (CBC) for Sepsis Diagnosis and Prognosis 96
NUOVE STRATEGIE TERAPEUTICHE E DIAGNOSTICHE PER IL MANAGEMENT DEL RISCHIO CARDIO-METABOLICO IN PAZIENTI CON NAFLD CON O SENZA DIABETE MELLITO TIPO 2 95
FIBROSIS DIAGNOSTIC SCORES VALIDATION IN OBESE PATIENTS WITH NON-ALCOHOLIC LIVER DISEASE 94
Future perspectives of the pharmacological management of diabetic dyslipidemia 94
Natural approaches in metabolic syndrome management 93
Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis 92
Diabetes and colorectal cancer risk: A new look at molecular mechanisms and potential role of novel antidiabetic agents 91
The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis 90
Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study. 88
Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases 84
Establishing sex- and age-related reference intervals of serum glial fibrillary acid protein measured by the fully automated lumipulse system 83
Novel therapeutical approaches to managing atherosclerotic risk 83
Outcome predictors in SARS-CoV-2 disease (COVID-19): The prominent role of IL-6 levels and an IL-6 gene polymorphism in a western Sicilian population 82
Independent validation of sepsis index for sepsis screening in the emergency department 82
Pharmacotherapy for gestational diabetes 81
Monocyte distribution width (MDW) kinetic for monitoring sepsis in intensive care unit 80
Polyphenols: Potential use in the prevention and treatment of cardiovascular diseases 80
Monocyte distribution width (MDW) as a screening tool for early detecting sepsis: a systematic review and meta-analysis 80
Monocyte Distribution Width (MDW) as a biomarker of sepsis: An evidenced-based laboratory medicine approach 79
Validation of monocyte distribution width decisional cutoff for sepsis detection in the acute setting 79
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes 77
Monocyte distribution width kinetic after surgery 76
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas? 76
Preliminary reference intervals of Glycated Albumin in healthy Caucasian pregnant women 76
Evaluation of core Biomarkers of Alzheimer’s disease in saliva and plasma measured by chemiluminescent enzyme immunoassays on a fully automated platform 75
Recent Updates and Advances in the Use of Glycated Albumin for the Diagnosis and Monitoring of Diabetes and Renal, Cerebro- and Cardio-Metabolic Diseases 74
The Role of Killer Ig-like Receptors in Diseases from A to Z 73
Role of Multiple Vitamin D-Related Polymorphisms in Multiple Sclerosis Severity: Preliminary Findings 73
Circulating histones contribute to monocyte and MDW alterations as common mediators in classical and COVID-19 sepsis 71
Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease 69
Validation of glycated albumin reference interval in healthy Caucasian pregnant women 67
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus 66
Thrombocytopenia and hyperinflammation are induced by extracellular histones circulating in blood 64
Evaluation of the analytical performance of three chemiluminescence serological assays for detecting anti-SARS-CoV-2 antibodies 63
Prevalence and heterogeneity of antinuclear antibody patterns in adult Italian patients with autoimmune liver diseases: Our experience 62
Microglial Activation and Priming in Alzheimer’s Disease: State of the Art and Future Perspectives 62
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study 61
Biomarkers of Nutritional Status 61
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes 60
Dyslipidemias 60
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update 59
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect 52
Longitudinal analysis of anti-SARS-CoV-2 S-RBD IgG antibodies before and after the third dose of the BNT162b2 vaccine 51
Genetic and Epigenetic Biomarkers For Diagnosis, Prognosis and Treatment Of Metabolic Syndrome 48
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies 47
Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis 46
Multiple Sclerosis Pathogenesis: Possible Interplay between Vitamin D Status and Epstein Barr Virus Infection 46
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes 45
Monocyte distribution width alterations and cytokine storm are modulated by circulating histones 42
Totale 11.366
Categoria #
all - tutte 51.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021597 0 0 0 0 0 49 42 98 126 130 78 74
2021/20221.201 64 126 124 52 44 76 50 118 107 153 115 172
2022/20231.793 135 278 56 172 143 276 137 153 199 50 112 82
2023/2024976 39 97 80 68 62 156 170 55 39 49 49 112
2024/20252.239 51 189 124 181 91 112 201 128 155 242 298 467
2025/20262.883 451 213 477 654 710 378 0 0 0 0 0 0
Totale 11.606